Combating Resistance: Microbes and Vectors

The development of effective antimicrobial treatments is one of the major advances of modern medicine.  Today, the emergence and spread of antimicrobial resistance (AMR) has far reaching consequences for medical procedures and treatments, with many common drugs and interventions potentially rendered ineffective.  It is estimated that 700,000 people die across the world every year due to the resistance to treatment of infections including bacterial infections, malaria, HIV/AIDS, fungal infections and tuberculosis.  Considering the threat that microbes and vectors resistance represent at the global scale, the Institut Pasteur has decided to focus the 4th edition of the Institut Pasteur International Network Symposium on these major issues.  It will in particular bring together scientists, clinicians and public health experts to:

 

  • Showcase high-level research to identify, monitor or predict the emergence of resistant pathogens and vectors;
  • Highlight the current efforts in translational science to develop new tools and technologies necessary to tackle the challenges of diagnostic and surveillance of these health threats;
  • Examine innovative solutions to practically develop these tools on the field in resource-limited settings.

 

For more information, please click here.